ライフサイエンスコーパス: enroll

1 tion from January 2008 to December 2018 were enrolled.

2 follow-up examinations were retrospectively enrolled.

3 A and 1,506 of their household contacts were enrolled.

4 ients (mean age 72 years old; 52% male) were enrolled.

5 ent-dependent cytotoxicity crossmatches were enrolled.

6 One hundred eyes of 76 patients were enrolled.

7 One hundred forty-five subjects were enrolled.

8 o were eligible for treatment with TACE were enrolled.

9 fficile nucleic acid amplification test were enrolled.

10 2016 to June 2018 in a tertiary center were enrolled.

11 One eye per patient was enrolled.

12 stable and 14 matched healthy controls were enrolled.

13 s and Main Results: Forty-five patients were enrolled.

14 ients ALVC (53 [48-59] years, 60% male) were enrolled.

15 6/150 [31%]) or Ecc (104/150 [69%]) BSI were enrolled.

16 , with a mean age of 60.8+/-11.3 years, were enrolled.

17 236) with S aureus-colonized parent(s) were enrolled.

18 From 2015 to 2017, we enrolled 1-to-1 matched intussusception cases and hospit

19 ed, placebo-controlled trial we sequentially enrolled 1.5-45 year-olds (N=148) into four age-descendi

20 Of the 1,800 patients enrolled, 1,652 with creatine kinase and/or creatine kin

21 This prospective study enrolled 100 healthy eyes of 100 patients, with ages ran

22 Of 128 enrolled, 100 participants met inclusion criteria (mean

23 2, 2016, and Jan 29, 2018, 303 patients were enrolled (105 to placebo, 96 to ixekizumab Q4W, and 102

24 Between Nov 1, 2017, and Aug 3, 2018, we enrolled 118 patients, of whom 59 were randomly assigned

25 We prospectively enrolled 120 patients with ischemic, 60 patients with di

26 We prospectively enrolled 121 patients between October 2015 and January 2

27 Between July 15, 2016, and July 20, 2018, we enrolled 1213 patients.

28 We enrolled 1242 of 1397 adults (89%) living in 533 househo

29 everaging diverse recruitment methods, sites enrolled 15 076 participants from April 2016 to June 201

30 Of the 229 patients enrolled, 153 were randomly assigned to receive luspater

31 We enrolled 156 patients with a mean age of 56 years; 78 pa

32 n in this genotype.Methods: We prospectively enrolled 166 related individuals, removing lung index ca

33 From 2014 to 2018, we enrolled 179 pregnant women into 4 groups: "HLHS/TGA" fe

34 Of 207 patients enrolled, 183 were in the microbiological intent-to-trea

35 eviewed a total of 227 glaucomatous eyes (38 enrolled, 189 excluded) during an interval of 5 years.

36 We enrolled 20 899 outpatients, of whom 2116 (10.1%) had po

37 t surgical intervention were retrospectively enrolled (2014-2015) and monitored for 1 year.

38 13, 2013, and May 3, 2016, 476 patients were enrolled (240 in the busulfan group received treatment a

39 We enrolled 243 patients; 141 (58%) were men, and 102 (42%)

40 omized double-blind placebo-controlled trial enrolled 252 participants (210 vaccine/42 placebo; media

41 Methods: This prospective multicenter study enrolled 260 men between 2015 and 2017.

42 Between April 6 and May 9, 2020, we enrolled 2766 participants from 1339 households, with a

43 Total of 661 TIA patients were enrolled, 279 of whom were DWI positive and 281 used DAP

44 Seventy-five primary care practices enrolled 3,200 patients with established hypertension.

45 Between Sept 17, 2015, and May 11, 2017, we enrolled 30 participants (six per panel).

46 The trial enrolled 30,420 volunteers who were randomly assigned in

47 We enrolled 30,529 participants between 25 March and 7 June

48 ods: Pooled analysis of two separate studies enrolling 30 patients undergoing bilateral bronchial rhe

49 We enrolled 31 841 households (53 926 children) in Banglade

50 The trial enrolled 31 patients who received bendamustine on days 1

51 Between April 15, 2014, and Oct 1, 2017, we enrolled 323 women, of whom 234 had perinatal HIV infect

52 We enrolled 351 pregnant women and 109 controls with epilep

53 ne hundred households with 800 contacts were enrolled: 353 (44.1%) individuals aged <=17 years with a

54 enter, open-label, randomized, control trial enrolled 360 children who were equally randomized to rec

55 A total of 290 adolescents were enrolled (41 or 42 per arm).

56 A total of 95 patients were enrolled; 43 patients were assigned to the intervention

57 Between Nov 3, 2015, and Dec 29, 2018, we enrolled 478 patients and 462 unique patients were inclu

58 Seventy-five women were enrolled: 52 (69%) were HIV+ with three-fourths having u

59 The national Canadian cohort enrolled 542 patients with TOF or PS and mild to severe

60 Among 26 221 diarrhea patients enrolled, 6.2% (n = 1604) cases were V. cholerae O1.

61 We enrolled 612 eyes of 391 subjects with progressive kerat

62 linded, placebo-controlled, randomized trial enrolled 70 patients with HFrEF from March 6, 2018, to S

63 743 adults were enrolled; 741 received >=1 dose of study drug (DTG/3TC,

64 The trial intended to enroll 800 mothers, but was stopped earlier.

65 PG) fuel/stove randomized intervention trial enrolling 800 pregnant women in each of four countries (

66 We enrolled 821 asymptomatic participants.

67 The REMEMBER randomized clinical trial enrolled 850 participants with HIV (CD4 < 50 cells/uL) a

68 ter, double-blind, randomized clinical trial enrolling 881 patients with an ejection fraction <=40%.

69 We enrolled 93 PHIV and 99 HIV-uninfected females.

70 ants who were HIV/HCV antibody positive were enrolled (95% male [80% gay and bisexual men,], 13% cirr

71 REPRIEVE enrolled a diverse cohort including a substantial number

72 with EG and control subjects without EG were enrolled across 9 Consortium of Eosinophilic Gastrointes

73 A total of 1447 patients were enrolled across the VCs, including 737 in the standard c

74 multicentre, open-label, phase 1b study, we enrolled adult patients (aged >=18 years) with locally a

75 We enrolled adult patients (aged >=18 years) with relapsed

76 This phase III trial enrolled adult patients with brain metastases to HA-WBRT

77 We enrolled adults who had household or occupational exposu

78 ) <32 weeks and/or birth weight <1500 g were enrolled after birth.

79 Forty-two of 53 consecutive patients were enrolled after giving informed consent and fulfilling st

80 23 and Nov 4, 2020, 23 848 participants were enrolled and 11 636 participants (7548 in the UK, 4088 i

81 ean [SD] age, 61 [14] years; 37% women) were enrolled and all completed follow-up.

82 In total, 296 premature infants were enrolled and compared with a control group of 66 healthy

83 tive cohort study in Lima, Peru, in which we enrolled and followed 14 044 household contacts of adult

84 In part 2, 1-11 year-olds (N=212) were enrolled and randomized 3:1 to TAK-003 or placebo groups

85 Eighty subjects were consecutively enrolled and randomized among 4 groups (continuation of

86 ts with suspected or confirmed COVID-19 were enrolled and randomized within at least 1 domain followi

87 Four hundred one participants were enrolled and randomized, and 13 participants did not pro

88 d Nov 12, 2018, 1152 mother-child dyads were enrolled and randomly assigned (n=376 group-only interve

89 Between Feb 15 and Sept 10, 2017, we enrolled and randomly assigned 49 healthy adult particip

90 6, 2013, and Feb 6, 2019, 1087 patients were enrolled and randomly assigned to either the VRd regimen

91 7, 2015, and Aug 4, 2016, 432 patients were enrolled and randomly assigned to receive either venetoc

92 e 1, 2007, and Aug 14, 2013, 1208 women were enrolled and randomly assigned to receive no tumour bed

93 , and Oct 1, 2018, 81 eligible patients were enrolled and randomly assigned to the pazopanib group (n

94 013, 800 pregnant women living with HIV were enrolled and randomly assigned to the single-dose (n=266

95 Over 11 seasons, 6954 children with AGE were enrolled and submitted a stool specimen (2187 hospitaliz

96 Patients were enrolled and treated in a phase 1 adult, a phase 1/2 pae

97 atients with TRK fusion-positive cancer were enrolled and treated with larotrectinib.

98 Thirty-five patients were enrolled, and 29 were included in the primary efficacy a

99 Thirty-five patients were enrolled, and 33 patients were evaluable for efficacy.

100 A total of 730 patients were enrolled, and 3407 wishes were elicited.

101 Seventy-five patients were enrolled, and extubation failure was noted in 18 (24%) p

102 y, KFDV-positive patients were prospectively enrolled, and repeated peripheral blood collections were

103 Most studies enrolled any adult aged 18 years or older.

104 Nonpregnant women with epilepsy were enrolled as controls and had similar follow-up during an

105 hods This prospective longitudinal MRI study enrolled astronauts with planned long-duration spaceflig

106 Patients were enrolled at 16 clinical centers and were assigned random

107 Of the first 259 participants enrolled at 20 sites, 222 had completed short-term follo

108 5 years) planning infertility treatment were enrolled at 4 US reproductive endocrinology and infertil

109 A total of 1005 patients were enrolled at 49 sites in Brazil.

110 =4) with a bodyweight of 40 kg or more, were enrolled at 69 sites in Australia, Canada, Europe, and t

111 sults of an interim analysis of 316 patients enrolled at Houston Methodist hospitals from March 28 to

112 nd ONH was obtained for a subset of patients enrolled at participating sites.

113 Participants were enrolled at seven community sites in six countries (two

114 nd/or life-threatening COVID-19 disease were enrolled at the Houston Methodist hospitals from March 2

115 17, all household contacts of DR-TB patients enrolled at the Indus Hospital were screened for TB symp

116 usions: Noninferiority trials of LTBI should enroll based on the most specific diagnostic tests avail

117 even if as many as 70% of participants were enrolled based on positive TST.Conclusions: Noninferiori

118 Enrolling based on a mix of TST and IGRA substantially r

119 Enrolling based on no test or regardless of test result

120 ood of falsely declaring noninferiority over enrolling based on TST alone, even if as many as 70% of

121 9 888 in 2004 to 41 121 in 2017 among dually enrolled beneficiaries (P < .001) and from 29 000 in 200

122 00 in 2004 to 22 601 in 2017 among nondually enrolled beneficiaries (P < .001); however, the differen

123 beneficiaries aged 65 years or older, dually enrolled beneficiaries had higher annual all-cause morta

124 elated outcomes between dually and nondually enrolled beneficiaries persisted during the study period

125 on-related mortality compared with nondually enrolled beneficiaries.

126 In 376 776 UK Biobank participants enrolled between 2006 and 2010, we tested alcohol consum

127 iology of COPD (COPDGene) study participants enrolled between 2007 and 2011 included those with basel

128 udy of 16,415 adults in 4 US cities who were enrolled between 2008 and 2011.

129 ption cohort study of North American couples enrolled between 2013 and 2019.

130 udes patients with CS from 8 medical centers enrolled between 2016 and 2019.

131 and 123 inexperienced surgical trainees were enrolled between April 2015 and November 2016.

132 tive), and healthy control (HC) participants enrolled between August 2017 and June 2018.

133 85 patients were enrolled between Feb 22, 2015, and Dec 31, 2018, and 75

134 dy included 239 sepsis patients admitted and enrolled between January 2015 and July 2017.

135 tudy participants with CF were prospectively enrolled between January 2017 and November 2017.

136 Participants were enrolled between March 2017 and March 2018 and followed

137 with aortic and/or valvular disease who were enrolled between May and August 2019.

138 RVd n=52, RVd-elotuzumab n=48) patients were enrolled between Oct 27, 2013, and May 15, 2016, across

139 BMI between 18.5 and 24.9) aged 18-45 y were enrolled between October 2018 and January 2019.

140 myopia and less than 1.00 D astigmatism were enrolled between September 22, 2014, and June 20, 2016.

141 21, 2019, 113 general practice clinics were enrolled, but four clinics dropped out shortly after ran

142 strated: (1) Based on the high percentage of enrolled, but ineligible patients, it is clear that adhe

143 s of the prospective CKiD Cohort Study which enrolled children with an eGFR of 30-90 ml/min per 1.73

144 ombitasvir, dasabuvir, with ribavirin) that enrolled chronic genotype 1a HCV-infected persons coinfe

145 ogression as well as a compendium of active, enrolling clinical trials for this population.

146 In five intensive care units (ICUs), we enrolled conscious, critically ill adults who had a trac

147 We enrolled consecutive patients with paroxysmal or persist

148 e quantified in serum from 321 prospectively enrolled critically ill patients and compared with clini

149 We enrolled double-blind, randomised controlled trials (RCT

150 December 2016-February 2018, 32 of 198 (16%) enrolled DR-TB HIV patients were identified as dual adhe

151 Patients were enrolled during hospitalisation for acute heart failure

152 trials, increasing the diversity of patients enrolled, evaluating strategies to streamline registries

153 In a double-blind, placebo-controlled trial enrolling females with dry skin, 2% IDL lotion applied o

154 tients (50 Gy, n = 937; 40 Gy, n = 917) were enrolled from 2009-2014 from eight centers.

155 dynamic cohort of children aged 0.5-10 years enrolled from August 2011 to June 2017 in Nagongera Subc

156 orectal surgery with primary anastomosis was enrolled from January 2016 to December 2018.

157 proliferative diabetic retinopathy who were enrolled from November 2016 to December 2017.

158 Patients (N = 167) enrolled from November 21, 2016, to April 20, 2017.

159 rsistent AF referred for first ablation were enrolled from October 2013 through June 2018.

160 cancer diagnosed between 2009 and 2015 were enrolled from the Second Affiliated Hospital of Zhejiang

161 The LAAO Registry has enrolled >38,000 patients implanted with the device.

162 rospective population-based cohort study, we enrolled healthy children residing in Bogo or Balamban,

163 inese patients with type 2 diabetes who were enrolled in 2007-2015.

164 Enrolled in 2016-2017, participants received sofosbuvir/

165 721 subjects (age, 68+/-13 years; 22% black) enrolled in 3 acute heart failure clinical trials: ROSE-

166 A subset of patients (n = 116) enrolled in 3 phase-3 randomized clinical trials (AMAGIN

167 inical Research Network stage F3 or F4) were enrolled in 4 multinational clinical trials of simtuzuma

168 +/- 3.4 kg/m2; age: 45.4 +/- 8.2 y; 33 men) enrolled in a 1000-kcal/d diet for 8 wk, followed by 4 w

169 In a cohort of infants enrolled in a clinical trial of maternal influenza vacci

170 Twenty-one adolescents with TS were enrolled in a double-blind, randomized, sham-controlled,

171 Healthy volunteers were enrolled in a double-blinded, placebo-controlled, crosso

172 rds of all Medicaid recipients are currently enrolled in a health maintenance organization (HMO).

173 milk samples were collected from 285 mothers enrolled in a high-allergy-risk birth cohort, the Melbou

174 nvasively ventilated on controlled modes and enrolled in a large, multinational, epidemiological stud

175 particles from 89 patients with AH who were enrolled in a multicenter observational study, 36 with a

176 ot study, 28 lung transplant recipients were enrolled in a novel postdischarge home monitoring progra

177 Patients with advanced ACC were enrolled in a phase II study to evaluate the clinical ac

178 eated with neoadjuvant chemoradiation (NACR) enrolled in a phase III clinical trial.

179 We studied patients enrolled in a randomized clinical trial and used complem

180 Participants were enrolled in a study of cerebrospinal fluid (CSF) abnorma

181 ge: 35.2 +/- 6.3 y; 88 whites and 83 blacks] enrolled in a weight-loss program to achieve a BMI <25,

182 nt-free survival (EFS) rate for all patients enrolled in AALL0331 was 88.96% +/- 0.46%, and overall s

183 currently in a major depressive episode were enrolled in an open-label study and received ezogabine u

184 included older females (n = 998; aged 73-87) enrolled in both the Women's Health Initiative Study of

185 examine the effect of prior CRT in patients enrolled in COAPT.

186 reported in claims databases for all adults enrolled in fee-for-service Medicare and for roughly 9 m

187 ve performance in a subset of 1,204 patients enrolled in FOURIER (Further Cardiovascular Outcomes Res

188 gh-resolution omics screening to populations enrolled in large-scale observational and clinical trial

189 y number among 5,502 Mexican American adults enrolled in Mano-A-Mano, the Mexican American Cohort Stu

190 tion period, patients had to be continuously enrolled in Medicaid for 6 months after buprenorphine di

191 eneficiaries, 11 697 900 (16.5%) were dually enrolled in Medicare and Medicaid for at least 1 month.

192 l pain, and of these 199 (69%) patients were enrolled in our study.

193 Twenty four subjects were enrolled in part 1 (n = 8 per cohort, randomized 3:1 MMV

194 3:1 MMV390048:placebo) and 15 subjects were enrolled in part 2 (40 mg [n = 7] and 80 mg [n = 8] coho

195 We studied 53 newly diagnosed subjects enrolled in placebo groups of TrialNet clinical trials.

196 Of the cohort (n = 7776), 52% enrolled in QHPs.

197 with HLA-A*02.01+ and H3.3K27M+ status were enrolled in stratum A (DIPG) or stratum B (nonpontine DM

198 For the present analysis, among patients enrolled in the ART (n=3102), we excluded those who did

199 scitated from out-of-hospital cardiac arrest enrolled in the CCC trial (Trial of Continuous or Interr

200 Data from 3,939 participants enrolled in the Chronic Renal Insufficiency Cohort (CRIC

201 d mononuclear cells (PBMC) RNA from subjects enrolled in the Clinical Trials in Organ Transplantation

202 female; mean age 56.7 years [SD 13.8]) were enrolled in the DCSS and followed up for a median of 9.7

203 Two cohorts of kidney transplant recipients enrolled in the Deterioration of Kidney Allograft Functi

204 We performed a post hoc analysis of patients enrolled in the DIVA (Drug-Eluting Stents Versus Bare Me

205 ng CT and clinical data in 1962 participants enrolled in the Evaluation of COPD Longitudinally to Ide

206 bset of patients not on oral anticoagulation enrolled in the Evolut Low Risk randomized trial underwe

207 11,834 participants enrolled in the German population-based Gutenberg Health

208 baseline observation period, family members enrolled in the intervention phase were given an informa

209 dy assessed the 10-year outcomes of patients enrolled in the ISAR-TEST-5 (Test Efficacy of Sirolimus-

210 were receiving bisphosphonates and who were enrolled in the Kaiser Permanente Southern California he

211 sy-confirmed pancreatic cancer of any stage, enrolled in the KYT programme and who received molecular

212 eligible enumerated residents not previously enrolled in the longitudinal cohort participated in the

213 valence and incidence of MG infection in MSM enrolled in the open-label phase of the ANRS IPERGAY tri

214 ) in the bone marrow of 285 patients with MM enrolled in the PETHEMA/GEM2012MENOS65 trial (#NCT019162

215 ts (ages 33-68 years; median, 55 years) were enrolled in the phase Ib study.

216 rus (HIV)-negative children aged 1-59 months enrolled in the Pneumonia Etiology Research for Child He

217 f relapse (CIR) in patients with NPM1mut AML enrolled in the randomized phase 3 AMLSG 09-09 trial.

218 formation was collected from 793 individuals enrolled in the Rett and Rett-Related Disorders Natural

219 carditis pain and an elevated CRP level were enrolled in the run-in period.

220 icipants with median adherence of <=80% were enrolled in the SEE program.

221 ildren (excluding ten healthy controls) were enrolled in the seven studies and the sample sizes range

222 Of 1316 patients with HIV enrolled in the STAMP trial at the Malawi site between O

223 7, 62 patients with epithelioid sarcoma were enrolled in the study and deemed eligible for inclusion

224 oyees of a large hospital in Boston, MA, who enrolled in the study between September 2016 and Februar

225 Twenty women, median age 29.7 years, enrolled in the study, with 10 in phase 1 and 10 in phas

226 Results: Sixty-eight patients were enrolled in the study.

227 (SH) age- and sex-matched children (C) were enrolled in the study.

228 alveolar lavage fluid (BALF) of participants enrolled in the SubPopulations and InteRmediate Outcome

229 ho had been randomly assigned in SPRINT were enrolled in the substudy (1448 received intensive treatm

230 ed participant-level data for pregnant women enrolled in the SUSTAIN and REFINE studies between Jan 1

231 111 farm families and 129 non-farm families enrolled in the Wisconsin Infant Study Cohort birth coho

232 Patients were enrolled in this long-term extension from April 1, 2011,

233 2, 2001 and December 31, 2005 in Sweden were enrolled in this population-based, nationwide, and prosp

234 19 infection who had undergone chest CT were enrolled in this retrospective study.

235 Methods: Twenty-seven healthy adults enrolled in this study.

236 RD prospective cohort from 2008 to 2014 were enrolled in this study.

237 a prospective cohort study of 2,466 children enrolled in Toronto, Ontario, Canada, between 2008 and 2

238 A total of 33 participants were enrolled, including 13 AD(-)PA(+), 9 AD(+)PA(+), and 11

239 Ct data were available for 106 (71%) of 150 enrolled index patients.

240 oidal Salmonella (NTS) was identified in 671 enrolled inpatients (1.8% of all enrolled inpatients, 13

241 s (1.8% of all enrolled inpatients, 13.8% of enrolled inpatients with a positive culture).

242 fied in 671 enrolled inpatients (1.8% of all enrolled inpatients, 13.8% of enrolled inpatients with a

243 hnic adult patients with biopsy-proven NAFLD enrolled into 4 different studies conducted by the Nonal

244 confirmed sickle cell disease, 41 (75%) were enrolled into a programme for free folic acid and penici

245 ive adolescent females aged 15-19 years were enrolled into a substudy of UChoose, an open-label rando

246 A total of 54 patients were enrolled into healthy, peri-implant mucositis, and peri-

247 , n=1321 from intervention communities) were enrolled into the 20% longitudinal cohort at baseline fr

248 hers participating in the INSIGHT study were enrolled into the observation-only ancillary study, SIBS

249 otal of 140 patients with definite ARVC were enrolled (mean age 42 +/- 17 years, 97 males) in this mu

250 Among the 840 participants who enrolled (mean age, 59.3 years [SD, 8.6 years]; 60% fema

251 Among 826 patients enrolled (mean age, 68 [SD, 7] years; 91 women [12%]), 7

252 Between September 2018 and March 2019, we enrolled men who have sex with men with nucleic acid amp

253 o had suitable vessels for AVF creation were enrolled (n = 162).

254 A number needed to treat/enroll (NNT) for 1 additional person to achieve viral su

255 e Brazilian referral maternity hospitals and enrolling nulliparous women at 19-21 weeks.

256 The first patient with ENKTL was enrolled on Feb 15, 2007, and the last on May 26, 2017.

257 ents with AML >= 60 years were prospectively enrolled on the ongoing Beat AML trial (ClinicalTrials.g

258 8, 2012, and Oct, 20, 2015, 68 patients were enrolled on the study (49 in cohort one, six in cohort t

259 We enrolled paediatric or adult patients in two ongoing, mu

260 We tested stools from enrolled participants and non-diarrheal controls for ent

261 The median age of enrolled participants is 21 years (range 0-93 years).

262 Enrolled participants were randomly assigned (1:1) to re

263 0 distinct development trajectories (267 343 enrolled participants) were identified.

264 We evaluated guidelines to enroll patients, including visual acuity minimums, exclu

265 We enrolled patients (aged 3-64 years) presenting to two Ka

266 We enrolled patients admitted to hospital with suspected or

267 ional, prospective, non-interventional study enrolled patients aged >=18 years scheduled to receive D

268 prospective, observational cohort study, we enrolled patients aged 6 months to 18 years with newly p

269 ed with breast cancer at age <= 40 years and enrolled patients between 2006 and 2016 (N = 1,302).

270 Four enrolled patients did not undergo the protocol because o

271 Two enrolled patients died within 3 months of treatment from

272 All enrolled patients received at least one dose of study tr

273 The enrolled patients underwent 215 US, 167 CT, and 69 MRI e

274 Enrolled patients underwent perimetry at baseline and an

275 The median age of the enrolled patients was 13 years (IQR 8-15).

276 320 isolates from 379 enrolled patients were available with susceptibility to

277 We enrolled patients who underwent kidney transplantation a

278 We enrolled patients with a controlled primary malignancy a

279 acute care hospitals in eight countries, we enrolled patients with acute ischaemic stroke due to lar

280 We enrolled patients with metastatic RCC with no prior chec

281 In the first 55 consecutively enrolled patients with RET-mutant medullary thyroid canc

282 Of the 389 enrolled patients, 133 (34.2%) died within 180 days of I

283 Among 40 enrolled patients, 27 were assigned to focused ultrasoun

284 frequencies received at these facilities by enrolled patients.

285 A total of 333 enrolled persistent atrial fibrillation patients underwe

286 Ninety-nine trials (48%) enrolled populations with diverse musculoskeletal injuri

287 norovirus, 43 long-term care facilities were enrolled prospectively in 2010-2014.

288 of 69 years +/- 14 (standard deviation) were enrolled prospectively in the PROMeNADe registry (Clinic

289 ion estimated whether sex differences in not enrolling ("screen out") varied by various individual, t

290 and there was evidence of putative in-home (enrolled siblings) and outpatient clinic transmission.

291 Among 7770 participants enrolled, the median age was 50 years, 31% were female (

292 The study enrolled TIA patients within 72 h of onset from the pros

293 RAF(V600E)-mutated biliary tract cancer were enrolled to the study and were evaluable.

294 ClinicalTrials.gov (NCT03194932) and is now enrolling to address secondary and exploratory objective

295 A total of 590 participants enrolled via a web-based platform and responded to quest

296 Seventy-six patients were enrolled with a median age of 59 years (range, 40-76 yea

297 A total of 1203 LFII patients were enrolled with an average 1.7 HBR criteria per patient, i

298 nic-based dataset with 510 outpatients newly enrolled with diseases of infectious keratitis, non-infe

299 31, 2019), 258 patients (n = 184 GIST) were enrolled, with 68 patients in the dose-escalation phase.

300 rvical biopsy samples were obtained from all enrolled women.